CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 36.92% | -0.16% | -48.86% | |
| 2 | ✓ | Passage Bio INC | Stock-Other | 16.89% | — | — | |
| 3 | ✓ | Aligos Therapeutics INC | Stock-Other | 14.59% | — | — | |
| 4 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 9.74% | — | +1.29% | |
| 5 | 2JQ | Gritstone Bio INC | Stock-Other | 8.18% | — | — | |
| 6 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 6.05% | — | — | |
| 7 | AKRO | Akero Therapeutics INC | Stock-Other | 3.49% | — | -20.57% | |
| 8 | ✓ | Flexion Therapeutics INC | Stock-Other | 2.28% | — | -65.90% | |
| 9 | ✓ | Stock-Other | 1.25% | — | -11.69% | ||
| 10 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.48% | — | — | |
| 11 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.14% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | 2JQ | Gritstone Bio INC | +6.4% | — | Unchanged |
| 2 | ✓ | Aligos Therapeutics INC | +5.1% | — | Unchanged |
| 3 | ADVMCHF | Adverum Biotechnologies INC | +4.1% | +1.29% | Add |
| 4 | CRNX | Crinetics Pharmaceuticals In | +3.1% | — | Unchanged |
| 5 | AKRO | Akero Therapeutics INC | +1.4% | -20.57% | Trim |
| 6 | ✓ | +0.5% | -11.69% | Trim | |
| 7 | CBAYUSD | Cymabay Therapeutics INC | +0.2% | — | Unchanged |
| 8 | CLVSEUR | Clovis Oncology INC | +0.1% | — | Unchanged |
| 9 | ✓ | Flexion Therapeutics INC | -2.3% | -65.90% | Trim |
| 10 | CRSP | CRISPR Therapeutics AG | -11.4% | -48.86% | Trim |
| 11 | NARIUSD | Inari Medical INC | — | EXIT | Sold out |
| 12 | ✓ | Passage Bio INC | — | NEW | New buy |
| 13 | OCUL | Ocular Therapeutix INC | — | EXIT | Sold out |